IFNL1 and systemic lupus erythematosus: Increased IFN-λ1 expression in serum and skin lesions in patients with cutaneous lupus erythematosus has been reported, but our present study and previous reports indicate that the mucocutaneous inflammation in SLE is most probably driven by type I IFNs [8, 16].